Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 978 of 1,261
  1. US 7855190

    Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration

    TEVA WOMEN'S HEALTH, INC. · Granted Dec 21, 2010 · Expires Dec 16, 2030

    granted
  2. US 7855202

    Imidazopyridine derivatives as A2B adenosine receptor antagonists

    Laboratories Almirall, S.A. · Granted Dec 21, 2010 · Expires Dec 16, 2030

    granted
  3. US 7854932

    Immunogenic compositions comprising progastrin and uses thereof

    The Board of Regents of the University of Texas System · Granted Dec 21, 2010 · Expires Dec 16, 2030

    granted
  4. US 7855214

    Fused cyclic systems useful as inhibitors of TEC family protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Dec 21, 2010 · Expires Dec 16, 2030

    granted
  5. US 7855220

    Bicyclic derivatives as modulators of voltage gated ion channels

    Vertex Pharmaceuticals Incorporated · Granted Dec 21, 2010 · Expires Dec 16, 2030

    granted
  6. US 7855233

    Citrate salt of Rasagiline

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 21, 2010 · Expires Dec 16, 2030

    granted
  7. US 7855291

    Process for the preparation of substituted phenylalanines

    LEXICON PHARMACEUTICALS, INC. · Granted Dec 21, 2010 · Expires Dec 16, 2030

    granted
  8. US 7855221

    Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid

    Theravance, Inc. · Granted Dec 21, 2010 · Expires Dec 16, 2030

    granted
  9. US 7855191

    Agent having a destructive effect on malignant tumors and method for the production thereof

    C.Y.L. Pharmazeutika GmbH · Granted Dec 21, 2010 · Expires Dec 16, 2030

    granted
  10. US 7855276

    Framework residue substituted humanized COL-1 antibodies and their use

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 21, 2010 · Expires Dec 16, 2030

    granted
  11. US 7851495

    Thiophene-carboxamides useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Dec 14, 2010 · Expires Dec 9, 2030

    granted
  12. US 7851194

    West Nile viruses with mutations in the 3′ terminal stem and loop secondary structure for use as live virus vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 14, 2010 · Expires Dec 9, 2030

    granted
  13. US 7851631

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Dec 14, 2010 · Expires Dec 9, 2030

    granted
  14. US 7851480

    Spiro 2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Dec 14, 2010 · Expires Dec 9, 2030

    granted
  15. US 7851506

    Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy

    Jazz Pharmaceuticals, Inc. · Granted Dec 14, 2010 · Expires Dec 9, 2030

    granted
  16. US 7851473

    Amide compound

    Takeda Pharmaceutical Company Limited · Granted Dec 14, 2010 · Expires Dec 9, 2030

    granted
  17. US 7851565

    Stabilized polymeric thiol reagents

    Nektar Therapeutics · Granted Dec 14, 2010 · Expires Dec 9, 2030

    granted
  18. US 7851632

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Dec 14, 2010 · Expires Dec 9, 2030

    granted
  19. US 7851467

    Carbamate compounds as 5-HT4 receptor agonists

    Theravance, Inc. · Granted Dec 14, 2010 · Expires Dec 9, 2030

    granted
  20. US 7851445

    Angiogenic heparin-binding epitopes, peptide amphiphiles, self-assembled compositions and related methods of use

    Northwestern University · Granted Dec 14, 2010 · Expires Dec 9, 2030

    granted
  21. US 7851465

    Compositions and methods relating to novel compounds and targets thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 14, 2010 · Expires Dec 9, 2030

    granted
  22. US 7851449

    Peptide, pharmaceutical composition, and a method of treating microcirculation disorders

    Obschestvo S Ogranichennoi Otvetstvennostyu “Sia Peptides” · Granted Dec 14, 2010 · Expires Dec 9, 2030

    granted
  23. US 7850961

    Methods for targeting solid tumor stem cells in a solid tumor using a notch4 receptor antagonist

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 14, 2010 · Expires Dec 9, 2030

    granted
  24. US 7851169

    Compositions and methods for inhibiting squamous cell carcinoma

    The United States of America as represented by the Department of Veterans Affairs Office of the General Counsel · Granted Dec 14, 2010 · Expires Dec 9, 2030

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.